We undertook the present study to investigate the following in APC patients: (A) an appropriate cut-off value for serum GDF-15 levels; (B) the relationship between serum GDF-15 levels and clinical data; and (C) tumor characteristics associated with high serum levels of GDF-15. This evidence concerns the gene GDF15 and neoplasm.